Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00014625
What this trial is testing

E7070 in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT03235245
What this trial is testing

Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

Who this might be right for
Unresectable Stage III MelanomaStage IV Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 271
Testing effectiveness (Phase 2)Ended earlyNCT03595683
What this trial is testing

Pembrolizumab and EDP1503 in Advanced Melanoma

Who this might be right for
Melanoma (Skin)Melanoma
University of Chicago 8
Large-scale testing (Phase 3)Active Not RecruitingNCT04099251
What this trial is testing

Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 790
Testing effectiveness (Phase 2)Study completedNCT00003895
What this trial is testing

Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma

Who this might be right for
Recurrent MelanomaStage IA MelanomaStage IB Melanoma+6 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Looking for participantsNCT06365619
What this trial is testing

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

Who this might be right for
Melanoma
University of Utah 25
Early research (Phase 1)Looking for participantsNCT07475572
What this trial is testing

Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

Who this might be right for
Melanoma
Alvotech Swiss AG 120
Testing effectiveness (Phase 2)Study completedNCT01127451
What this trial is testing

Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

Who this might be right for
Stage IIIC MelanomaStage IV Melanoma
Eisai Inc. 75
Testing effectiveness (Phase 2)Study completedNCT00093119
What this trial is testing

Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma

Who this might be right for
MelanomaMetastases
Celgene 75
Testing effectiveness (Phase 2)Study completedNCT00568048
What this trial is testing

Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)
Swiss Cancer Institute 62
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07574047
What this trial is testing

MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

Who this might be right for
MelanomaAdvanced Melanoma
Swiss Cancer Institute 108
Early research (Phase 1)Looking for participantsNCT04697576
What this trial is testing

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Who this might be right for
Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8Clinical Stage IB Cutaneous Melanoma AJCC v8+6 more
Carlo Contreras 36
Testing effectiveness (Phase 2)Study completedNCT00471887
What this trial is testing

Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center 32
Testing effectiveness (Phase 2)WithdrawnNCT04007588
What this trial is testing

A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT02460224
What this trial is testing

Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 490
Testing effectiveness (Phase 2)Looking for participantsNCT06814496
What this trial is testing

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Who this might be right for
MelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more
University of Arizona 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT00539591
What this trial is testing

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

Who this might be right for
Malignant Melanoma
St. Jude Children's Research Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00022464
What this trial is testing

CCI-779 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00616564
What this trial is testing

Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Mt. Sinai Medical Center, Miami 36
Early research (Phase 1)Not Yet RecruitingNCT07581509
What this trial is testing

Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma

Who this might be right for
Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings)
Biocon Biologics UK PLC 138
Next Page